凝血酶原活性检测对各型肝病疗效和预后估计的意义  

The Significance of Detecting FⅡ:CA to Evaluate the Treatment and Prognosis for Patients with Liver Disease

作　　者：孙亚臣[1] 

机构地区：[1]北华大学医学院附属医院,吉林吉林132011

出　　处：《北华大学学报（自然科学版）》2001年第2期141-142,共2页Journal of Beihua University（Natural Science）

基　　金：吉林省卫生厅科学基金

摘　　要：目的检测各型肝病患者的凝血酶原活性,评价肝病的疗效和预后.方法巨齿蛇毒发色底物法检测各型肝病病人215例.结果各型肝病病人的凝血酶原活性都可出现不同程度的下降,并且下降的程度与病情的严重程度成正相关性.结论检测凝血酶原活性能准确地了解病人的肝功能,对判断各型肝病的疗效和预后的估计有重要意义.Objective?To detect the prothrombin coagulative activity(FⅡ:CA) of the patients with liver diseases and to evaluate the treatment and prognosis.Methods?215 patients with liver disease were detected with Eehis carinalus venom method of chromognic substance (ECV).Results?There were significant different descending in level FⅡ:CA of the patients with liver diseases and the degree of descending was correlative with the severity of the liver diseases.Conclusion?FⅡ:CA detection is important significance for appraising the treatment and prognosis for the patients with liver diseases.

关 键 词：肝病 凝血酶原活性 肝细胞合成 凝血因子 疗效估计 预后估计 活性检测 

分 类 号：R575.02[医药卫生—消化系统]